BTPABA

BTPABA Uses, Dosage, Side Effects, Food Interaction and all others data.

BTPABA is a dipeptide that is used in the bentiromide test, which is a screening test for evaluating pancreatic exocrine function and monitoring the adequacy of supplemental pancreatic therapy. It is typically administered orally. Cases of headache and gastrointestinal disturbances have been reported with the use of bentiromide. BTPABA is currently not available in the U.S. or Canada.

BTPABA is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. The amount of p-aminobenzoic acid and its metabolites excreted in the urine is the quantitative measure of the chymotrypsin-secreting activity of the pancreas.

Table Of contents

• BTPABA
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	BTPABA
Generic	Bentiromide
Bentiromide Other Names	Bentiromide, Bentiromido, Bentiromidum, BTPABA
Type
Formula	C23H20N2O5
Weight	Average: 404.4153 Monoisotopic: 404.13722176
Groups	Investigational, Withdrawn
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Indicated as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy.

How BTPABA works

BTPABA is a peptide that is broken down in the pancreas by chymotrypsin. By determining the output of unchanged bentiromide in the urine following oral administration, it is possible to determine the sufficiency of pancreatic activity.

Toxicity

Symptoms of overdose include shortness of breath and troubled breathing.

Innovators Monograph

You find simplified version here BTPABA